Table 8. SUCRA value for each treatment under the outcomes of recurrence and distant metastasis.
| Outcome | ||
|---|---|---|
| Recurrence | Distant metastasis | |
| Ble + Cis + Ifo | 0.43 | 0.83 |
| Ble + Cis + MitoC + Vbl | 0.24 | 0.20 |
| Ble + Cis + Vbl | 0.21 | 0.56 |
| Ble + Cis + Vcr | 0.18 | 0.54 |
| Cis | 0.52 | 0.41 |
| Cis + Doc | 0.74 | 0.72 |
| Cis + Epi | 0.20 | 0.50 |
| Cis + Flu | 0.68 | 0.48 |
| Cis + Flu + Hyd | 0.67 | - |
| Cis + Ifo | 0.93 | - |
| Cis + Ifo + Pac | 0.91 | - |
| Cis + Methotrexate | 0.38 | 0.23 |
| Cis + Mitolactol | 0.47 | - |
| Cis + Pac | - | 0.23 |
| Cis + Topotecan | 0.66 | - |
| Cis + Vcr | 0.26 | 0.45 |
| Epi | 0.56 | 0.88 |
| Flu | 0.60 | 0.61 |
| Flu + MitoC | 0.71 | 0.61 |
| Hyd | 0.42 | 0.45 |
| Placebo | 0.24 | 0.28 |